ZURICH/BERLIN, May 4 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Monday:
ROCHE ROGN.S
The company has won emergency approval from the U.S. Food
and Drug Administration (FDA) for an antibody test to determine
whether people have ever been infected with the coronavirus.
urn:newsml:reuters.com:*:nL8N2CL00Z
It also aims to more than double production of its new
coronavirus antibody test to "significantly more than" 100
million tests a month by the end of the year, Roche's
diagnostics unit head told Reuters. urn:newsml:reuters.com:*:nFWN2CJ0OJ
ABB ABBN.S
New Chief Executive Bjorn Rosengren is determined to
decentralise the Swiss engineering group to improve its
performance, he told Swiss newspaper Neue Zuercher Zeitung in an
interview. urn:newsml:reuters.com:*:nL8N2CJ3UU
COMPANY STATEMENTS
* Swisscom SCMN.S Fastweb CEO Alberto Calcagno told
Italian newspaper Il Sole 24 he thought it was unlikely
Swissccom would sell the business. "We have just posted our 27th
quarter of growth. The numbers say how important we are within
the universe of Swisscom," Calcagno said.
* GAM Holding AG GAMH.S said it put in place a programme
to give it the option to buy back shares over a three-year
period, but had currently no plans to buy back shares in light
of the market environment. GAMH.S
* Relief Therapeutics RLFB.S said its net loss widened to
7.46 million Swiss francs last year, compared to a loss of
436,000 francs in 2018. RLFB.S
* Zur Rose Group ROSEG.S said a public prosecutor has
filed charges against its CEO in connection with mail-order of
non-prescription drugs and electronic prescribing. It denies the
accusations and says the proceedings will have no effect on its
current business performance. ROSEG.S
* IGEA IGPH.S said it will partner with Acalis For ALZ1
wholesale distribution in the U.S. urn:newsml:reuters.com:*:nFWN2CL034
* Bellevue Group BBN.S said it has successfully closed the
sale of Bank AM Bellevue to Quintet.
* Julius Baer BAER.S said it excercised option to redeem
outstanding perpetual tier 1 bonds issued on June 5, 2015 at par
value plus accrued interest.
* Newron Pharmaceuticals NWRN.S is abandoning development
of its drug sarizotan for Rett Syndrome.
* Aryzta ARYN.S said it got permission from lenders to
amend its covenants as it seeks to preserve cash and reduce
costs during the coronavirus crisis.
ANALYSTS' VIEWS
JULIUS BAER GRUPPE BAER.S : Citigroup raises price target to
38 Swisse francs to 35.5 Swiss francs
UBS GROUP AG UBSG.S : Berenberg cuts to hold from buy,
raises target price to 11 Swiss francs from 10.50 Swiss francs.
GEBERIT AG GEBN.S : Jefferies raises target price to 344.80
Swiss francs from 339.30 Swiss francs; Credit Suisse raises to
neutral from underperform, cuts target price to 450 Swiss francs
from 470 Swiss francs
STRAUMANN HOLDING AG STMN.S : Credit Suisse cuts target
price to 870 Swiss francs from 1030 Swiss francs
LEONTEQ AG LEON.S : Credit Suisse cuts target price to 43
Swiss francs from 51 Swiss francs
ECONOMY
Roughly 64% of hotel, restaurant, tourism and cable car
businesses that have received emergency loans say they can only
cover their fixed costs until the end of June, a poll by those
sectors' Swiss trade groups published on Friday said.
* Swiss April Manufacturing PMI due at 0730 GMT.
* SNB sight deposits due at 0800 GMT.
(Reporting by Zurich newsroom and Berlin Speed Desk)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))